Inventor · Starnberg, DE

Harald Duerr

13Patents
4h-index
41Co-inventors
56Inventor score

Filing activity: Mar 24, 2011 → Mar 27, 2025

Most-cited inventions

PatentTitleAreaCited byStatus
US9695233B2 Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases Chemistry; Metallurgy 33 Active
US11242396B2 Bispecific antigen binding molecules comprising anti-FAP clone 212 Chemistry; Metallurgy 9 Active
US10941205B2 Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use Chemistry; Metallurgy 8 Active
US11603411B2 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use Chemistry; Metallurgy 5 Active
US10106600B2 Bispecific antibodies Chemistry; Metallurgy 2 Active
US11787868B2 Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use Chemistry; Metallurgy 1 Active
US10683345B2 Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases Chemistry; Metallurgy 1 Active
US12030952B2 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use Chemistry; Metallurgy 1 Active
US11780919B2 Bispecific antigen binding molecules targeting OX40 and FAP Chemistry; Metallurgy 0 Active
US12275794B2 Bispecific antigen binding molecules comprising anti-FAP clone 212 Chemistry; Metallurgy 0 Active
US12145994B2 Bispecific antigen binding molecules capable of specific binding to CD40 and to fap Chemistry; Metallurgy 0 Active
US12358997B1 Bispecific anti-human A-beta/anti-human transferrin receptor antibodies Chemistry; Metallurgy 0 Active
US10316059B2 Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.